Health Condition 1: I158- Other secondary hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients suffering hypertension and hyperuricemia. 2. Age between 40-65 years. 3. Patients of all sexes. 4. Patients willing to avoid other uric acid and blood pressure lowering therapies during the study period.
Exclusion criteria
Exclusion criteria: 1. Severe cardiovascular conditions requiring emergency or invasive interventions. 2. Patient having psychological or mental instability. 3. Unconscious, non-ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients, mentally disabled people. 4. Pregnant and postpartum women, nursing mothers. 5. Immune-compromised condition. 6. Already been in homoeopathic treatment for any chronic illness for the last 6 weeks. 7. Simultaneous participation in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess change in Systolic blood pressure (SBP) and diastolic blood pressure (DBP) along with changes in serum uric acid levels.Timepoint: At the baseline and after every 4 weeks for 12 weeks of the treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess changes in quality of life using the EQ-5D-5L questionnaireTimepoint: At baseline and at 3 months. | — |
Countries
India
Contacts
The Calcutta Homoeopathic Medical College and Hospital